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abstract
 
Activation and desensitization kinetics of the rat P2X
 
1
 
 receptor at nanomolar ATP concentrations
were studied in 
 
Xenopus
 
 oocytes using two-electrode voltage-clamp recording. The solution exchange system used
allowed complete and reproducible solution exchange in 
 
 
 
0.5 s. Sustained exposure to 1–100 nM ATP led to a
profound desensitization of P2X
 
1
 
 receptors. At steady-state, desensitization could be described by the Hill equa-
tion with a K
 
1/2
 
 value of 3.2 
 
  
 
0.1 nM. Also, the ATP dependence of peak currents could be described by a Hill
equation with an EC
 
50
 
 value of 0.7 
 
 
 
M. Accordingly, ATP dose-effect relationships of activation and desensitization
practically do not overlap. Recovery from desensitization could be described by a monoexponential function with
the time-constant 
 
 
 
 
 
 
 
 11.6 
 
 
 
1.0 min. Current transients at 10–100 nM ATP, which elicited 0.1–8.5% of the maxi-
mum response, were compatible with a linear three-state model, 
 
C
 
-
 
O
 
-
 
D
 
 (closed-open-desensitized), with an ATP
concentration-dependent activation rate and an ATP concentration-independent (constant) desensitization rate.
In the range of 18–300 nM ATP, the total areas under the elicited current transients were equal, suggesting that
P2X
 
1
 
 receptor desensitization occurs exclusively via the open conformation. Hence, our results are compatible
with a model, according to which P2X
 
1
 
 receptor activation and desensitization follow the same reaction pathway,
i.e., without signiﬁcant 
 
C
 
 to 
 
D
 
 transition. We assume that the K
 
1/2
 
 of 3.2 nM for receptor desensitization reﬂects
the nanomolar ATP afﬁnity of the receptor found by others in agonist binding experiments. The high EC
 
50
 
 value
of 0.7 
 
 
 
M for receptor activation is a consequence of fast desensitization combined with nonsteady-state condi-
tions during recording of peak currents, which are the basis of the dose-response curve. Our results imply that na-
nomolar extracellular ATP concentrations can obscure P2X
 
1
 
 receptor responses by driving a signiﬁcant fraction of
the receptor pool into a long-lasting refractory closed state.
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INTRODUCTION
 
Extracellular ATP excites many neuronal and nonneu-
ronal tissues by activating P2X receptors, which consti-
tute a third major class of ligand-gated ion channels
(LGICs)* distinct from the nicotinic acetylcholine re-
ceptor (nAChR) superfamily and the glutamate re-
ceptor family (North, 1996). The seven known P2X
isoforms (designated P2X
 
1
 
 to P2X
 
7
 
) form multiple
functional homomultimeric and heteromultimeric
channels (Brake et al., 1994; Valera et al., 1994; Bo et
al., 1995; Chen et al., 1995; Buell et al., 1996; Collo et
al., 1996; Surprenant et al., 1996; Soto et al., 1997). Bio-
chemical and electrophysiological studies have demon-
strated that recombinant P2X receptors possess a tri-
meric architecture in contrast to the canonical penta-
meric architecture of the nicotinic superfamily members
(Nicke et al., 1998, 1999a, 2003; Stoop et al., 1999; Ret-
tinger et al., 2000).
In response to extracellular ATP, P2X receptors
open, within milliseconds, an integral ion channel non-
selectively permeable to monovalent cations such as
Na
 
 
 
 and K
 
 
 
 as well as divalent cations such as Ca
 
2
 
 
 
 (for
reviews see Burnstock, 1999; Mackenzie et al., 1999).
Based on their sensitivity to 
 
  
 
-methylene ATP and rate
of desensitization, two P2X receptor phenotypes can be
distinguished: (a) P2X
 
1
 
 and P2X
 
3
 
 receptors are 
 
  
 
-
methylene ATP-sensitive and desensitize rapidly in tens
or hundreds of milliseconds in the continuous presence
of agonist; and (b) P2X
 
2
 
, P2X
 
4
 
, P2X
 
5
 
, and P2X
 
7
 
 recep-
tors are insensitive to 
 
  
 
-methylene ATP and desensi-
tize only slowly on a timescale of tens of seconds. The
different rates of desensitization have been attributed
by mutational analysis to various structural motifs, in-
cluding NH
 
2
 
- and COOH-terminal domains (Werner et
al., 1996; Koshimizu et al., 1999) and a highly con-
served protein kinase C site (Boue-Grabot et al., 2000).
It should be noted that the term desensitization as used
in the present study refers to a reversible functional in-
activation by a conformational transition of the LGIC
itself rather than to down-regulation by LGIC internal-
ization and related cellular processes, which lead to a
reduction of the number of receptor molecules in a
given plasma membrane (Ennion and Evans, 2001).
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Abbreviations used in this paper:
 
 LGIC, ligand-gated ion channel;
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Desensitization of the P2X
 
1
 
 Receptor at Nanomolar ATP
 
The occurrence of fast receptor desensitization in
the presence of agonist was ﬁrst studied in detail for
the acetylcholine response at frog muscle end-plates
(Katz and Thesleff, 1957). Upon steady application of
acetylcholine, the end-plate becames refractory to ace-
tylcholine within seconds; sensitivity recovered slowly
after complete removal of acetylcholine. The absence
of detectable depolarization during recovery implied a
cyclic model for nAChR activation and desensitization
with the existence of two distinct conformations in the
absence of agonist: a closed resting state, 
 
C
 
, and a
closed desensitized state, 
 
D
 
, linked by an open state, 
 
O
 
.
If the agonist binds, the nAChR opens and then desen-
sitizes; upon washout, the agonist dissociates and the
nAChR returns to its resting condition without reopen-
ing. To account for the observation that a given agonist
concentration can produce little depolarization, yet
lead to pronounced desensitization, it was proposed
(Katz and Thesleff, 1957) and later experimentally con-
ﬁrmed (Changeux, 1990) that the unliganded desensi-
tized state of the nAChR features a much higher afﬁn-
ity for the agonist than the resting state. The cyclic re-
action scheme predicts that the low afﬁnity resting state
 
C
 
 can undergo a conformational transition without
ligand binding and opening into the high afﬁnity de-
sensitized state 
 
D
 
. In agreement with this model, 
 
 
 
20%
of the total nAChR population exists in the high afﬁn-
ity desensitized state even in the absence of agonist
(Changeux, 1990). Consequently, at low acetylcholine
concentrations, selective binding to the desensitized
nAChRs can occur, thus shifting the equilibrium from
the favored low afﬁnity resting state toward the desensi-
tized state. Sustained exposure to low levels of agonists
can thus result without activation in the accumulation
of a large fraction of receptors in desensitized states
and hence reduce neuronal excitability (Dani and Hei-
nemann, 1996). Regular fast receptor activation re-
quires comparably high agonist concentrations that al-
low for the occupancy of the low afﬁnity resting state of
the receptors.
In this study, we used whole-cell current recordings
in 
 
Xenopus
 
 oocytes to assess the kinetics of activation
and desensitization of the recombinant rat P2X
 
1
 
 recep-
tor. The aim of this study was to examine whether the
P2X
 
1
 
 receptor also desensitizes by subthreshold levels
of ATP like other LGICs. To this end, we preincubated
oocytes expressing the P2X
 
1
 
 receptor under voltage-
clamp conditions with submicromolar concentrations
of ATP for prolonged times. Our results demonstrate
that a 50% steady-state desensitization of the rat P2X
 
1
 
receptor can be achieved by an ATP concentration as
low as 3 nM, which elicits 
 
 
 
0.1% of the maximum cur-
rent recorded at nonpredesensitized P2X
 
1
 
 receptors.
These results are discussed in terms of current models
describing LGIC activation and desensitization kinetics.
 
A simple kinetic scheme is proposed to account for our
data on the P2X
 
1
 
 receptor.
 
MATERIALS AND METHODS
 
LGIC Expression in Xenopus Oocytes
 
Plasmids encoding the wild-type rat P2X
 
1
 
 subunit (EMBL/Gen-
Bank/DDBJ accession no. U14414) (Nicke et al., 1998) or the
muscle type nAChR (Witzemann et al., 1990; Nicke et al., 1999b)
have been described previously. Capped cRNAs were synthesized
from linearized templates with SP6 RNA polymerase (Amersham
Biosciences), puriﬁed by sepharose G50 chromatography and
phenol-chloroform extraction, and dissolved in 5 mM Tris/HCl,
pH 7.2, at 0.5 
 
 
 
g/
 
 
 
l using the optical density reading at 260 nm
for quantitation (OD 1.0 
 
 
 
 40 
 
 
 
g/
 
 
 
l). Follicle cell–free 
 
Xenopus
laevis
 
 oocytes were isolated as described previously (Schmalzing
et al., 1991) and injected with 50-nl aliquots of cRNA. Until elec-
trophysiological experiments took place, the injected oocytes
were incubated at 19
 
 
 
C in sterile oocyte Ringer’s solution (ORi:
90 mM NaCl, 1 mM KCl, 1 mM CaCl
 
2
 
, 1 mM MgCl
 
2
 
, and 10 mM
HEPES, pH 7.4) supplemented with 50 
 
 
 
g/ml of gentamycin.
 
Electrophysiology
 
Whole-cell currents were recorded 2–4 d after cRNA injection us-
ing the two-electrode voltage-clamp method. Microelectrodes
were prepared from borosilicate glass and ﬁlled with 3 M KCl.
The tips were broken to achieve electrical resistances below 1.0
or 1.5 M
 
 
 
 for the current and the potential electrode, respec-
tively. Currents were recorded with a Turbo TEC-05 ampliﬁer
(npi electronics), low-pass ﬁltered at 200 Hz, and sampled at 500
Hz (AD/DA-Converter INT-10; npi electronics) using a commer-
cially available software (EggWorks; npi electronics). The hold-
ing potential was 
 
 
 
60 mV in all experiments. For perfusion of
oocytes, a nominally Ca
 
2
 
 
 
-free ORi solution was used (designated
Mg-Ori), in which Ca
 
2
 
 
 
 was replaced by Mg
 
2
 
 
 
 to avoid activation
of endogenous Cl
 
 
 
 channels (Methfessel et al., 1986). All mea-
surements were performed at ambient temperature (20–22
 
 
 
C).
 
Agonist Application
 
To allow for rapid solution exchange, an oocyte-recording cham-
ber with a small bath volume of 
 
 
 
10 
 
 
 
l was combined with fast
bath perfusion at a constant ﬂow rate of 
 
 
 
200 
 
 
 
l/s. Solutions
were applied by the use of a manifold made of glass capillaries
and silicon tubing (Fig. 1 A). Current signals were elicited by
switching between ATP-free to ATP-containing Mg-ORi. Switch-
ing between solutions was attained by magnetic valves, which en-
abled computer-controlled applications of solution by using the
EggWorks software.
In experiments designed to determine the rate of entry into
desensitization at submicromolar ATP concentrations, oocytes
were used only once because of the slow recovery from desensiti-
zation of the P2X
 
1
 
 receptor. Oocytes were voltage-clamped to
 
 
 
60 mV and then continuously superfused with 3–100 nM ATP in
Mg-ORi for different lengths of time (20 s to 20 min). At the end
of the predetermined preincubation period, the residual peak
current was elicited by application of a saturating test pulse of 30
 
 
 
M ATP. The fraction of P2X
 
1
 
 receptors in the resting state was
then calculated by normalizing the residual peak current to the
mean current response to 30 
 
 
 
M ATP recorded at the same day
from a subgroup of the same cRNA-injected oocytes that had
never been incubated with ATP before. The control responses
used for normalization were recorded after preincubation peri-
ods in ATP-free Mg-ORI identical in duration to the respectiveT
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residual responses. The standard error of means was propagated
into error bars of the normalized values using the usual formulas
of error propagation.
 
Data Analysis
 
Responses were quantiﬁed by measuring the peak current ampli-
tude relative to the baseline holding current recorded immedi-
ately preceding agonist application. Agonist dose-response curve
parameters were determined by nonlinear curve ﬁtting of the
Hill equation to the data using Origin software (version 5.0; Mi-
crocal Corporation). Data are expressed as mean 
 
 
 
 SEM. Fur-
ther details of data analysis including the equations used are
given under 
 
results
 
 and in the ﬁgure legends.
 
Computer Simulations
 
For simulation of reaction schemes and sets of rate constants, the
software GEPASI was used (Mendes, 1993, 1997). To obtain ATP-
dependent data, the time courses of the receptor currents were
calculated with an appropriate set of rate constants. These simu-
lated receptor currents were then analyzed in the same manner
as the experimentally determined receptor currents.
 
RESULTS
 
Rate of Solution Exchange
 
The onset of the current of the muscle type nAChR
formed by 
 
    
 
 nAChR subunits activated by 30 
 
 
 
M
acetylcholine has been demonstrated to provide a reli-
able estimate of the speed of solution exchange around
 
Xenopus
 
 oocytes (Dilger and Brett, 1990; Costa et al.,
1994). By activating oocytes expressing the muscle
nAChR (Nicke et al., 1999b) with 5-s acetylcholine
pulses (30 
 
 
 
M), a current rise time t
 
10–90%
 
 of 
 
 
 
150 ms
was determined for a 10–90% increase of the peak cur-
rent amplitude. Repetitive activation of the same oo-
cyte in 1-min intervals with acetylcholine generated vir-
tually indistinguishable current traces (Fig. 1 B), thus
demonstrating the excellent reproducibility of the solu-
tion exchange. For data analysis and kinetic modelling,
only time constants were considered that were at least
one order of magnitude larger than the t
 
10–90%
 
 value of
the solution exchange.
 
Steady-state Desensitization of the P2X
 
1
 
 Receptor at 
Submicromolar ATP Concentrations
 
At the near-saturating micromolar ATP concentrations
typically used to activate the P2X
 
1
 
 receptor in electro-
physiological experiments, the inward current rises fast
to peak and then declines in 
 
 
 
1 s, leading to a com-
plete loss of the response in the sustained presence of
ATP as a result of receptor desensitization. Since recov-
ery from desensitization occurs at slow rate (
 
 
 
 
 
 
 
12 min,
see next paragraph), a long-lasting desensitized state
follows activation by pulse applications of high concen-
trations of ATP. Even at an ATP concentration as low as
100 nM, which elicits only 
 
 
 
10% of the maximum cur-
rent response, full desensitization occurs within a few
seconds of continuous exposure to ATP, as deduced
from the inability of a subsequent application of 30 
 
 
 
M
ATP to evoke any current response (compare Fig. 2 B).
This raises the question to what extent even smaller
ATP concentrations are able to desensitize the P2X
 
1
 
 re-
ceptor and at what rate this desensitization occurs.
To address this question, we superfused oocytes un-
der voltage-clamp conditions for different time periods
with Mg-ORi containing a deﬁned ATP concentration
ranging from 3–100 nM. At a predetermined time
Figure 1. Schematic draw-
ing of the fast solution ex-
change device. (A) Cross-sec-
tion (top) and top view
(bottom) of the perfusion
chamber. The oocyte is
placed in a small cavity pos-
sessing an internal volume of
10   l and superfused at a
constant ﬂow rate of  200
 l/s through a glass-capillary
of 1.2-mm internal diameter
connected with a manifold
(not depicted) that is ﬁxed by
a micromanipulator. Bath so-
lution exceeding the internal
volume of the cavity is re-
moved with a diaphragm
pump through a glass-capil-
lary mounted close to the
chamber cavity. Two Ag/AgCl
pellets are used for grounding the bath and as reference for the intracellular voltage electrode, respectively. (B) The onset of muscle type
nAChR currents was used to assess the speed of solution exchange. Shown are seven superimposed current traces elicited repetitively in
1-min intervals by 5-s 30  M acetylcholine pulses. A current rise time t10–90% of  150 ms was determined for a 10–90% increase of the cur-
rent amplitude.T
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point, the solution was switched to 30 
 
 
 
M ATP to elicit
the residual peak current response by activating all the
P2X
 
1
 
 receptors still present in the nondesensitized state
C. Fig. 2 A shows as an example of such an experiment
the individual current traces of oocytes, which were
ﬁrst superfused for 1, 3, or 5 min with 18 nM ATP in
Mg-ORi and then challenged with a test pulse of 30 
 
 
 
M
ATP for peak current determination. To avoid any bias
by incomplete recovery between repetitive applications
of ATP as a result of to the long-lived desensitization,
every oocyte was used only once for (residual) peak
current determination by 30  M ATP and discarded
thereafter. By referring to the control response to 30
 M ATP of oocytes superfused solely with ATP-free Mg-
ORi, it follows that the fraction of P2X1 receptors in the
desensitized state increased with time, such that after 5
min of exposure to 18 nM ATP only 10% of the maxi-
mum current response was left.
It is important to note that the term “desensitization”
as used in the present study refers to both (a) the decay
of the transient receptor current in presence of ATP,
and (b) the rate of entry of P2X1 receptors into the de-
sensitized state by preincubation in low ATP. To distin-
guish kinetically between the two phenomena, we use
the time constants  des and  od to characterize the rate
of current decay (a) and the onset rate of desensitiza-
tion (b), respectively. The time courses of onset of P2X1
receptor desensitization at 3–100 nM ATP in the super-
fusion bath are illustrated in Fig. 2 B. To account for
variable expression levels between different oocyte
batches, residual peak currents elicited by 30  M ATP
after various length of perfusion with Mg-ORi with low
ATP were normalized to peak currents elicited by 30
 M ATP in a subgroup of the same cRNA-injected oo-
cytes, which were never exposed to ATP before apply-
ing the 30  M ATP test pulse (control group). In a total
of 13 control subgroups that were analyzed during the
course of this study, the average current elicited by 30
 M ATP without preincubation amounted to 23.6  
2.1   A; the average standard error of the measure-
ments within the individual subgroups was 13.7   2%.
The normalized residual current responses were plot-
ted for each of the various ATP concentrations versus
time and the following monoexponential equation was
ﬁtted to the data
where  od signiﬁes the time constant of onset of desen-
sitization; It is the amplitude of the residual peak cur-
rent response after preincubation time period t, and Iss
is the amplitude of the residual peak current at the
It Imax t – τod ⁄ () Iss, + exp =
Figure 2. Desensitization of
the P2X1 receptor by incuba-
tion at submicromolar ATP
concentrations. (A) Shown
are current traces elicited by
saturating test pulses of 30
 M ATP after preincubation
of individual oocytes at 18 nM
ATP for the indicated time
period. (B) Rate of entry into
the desensitized receptor
state by preincubation in
ATP-containing Mg-ORI. De-
sensitization was induced us-
ing 3 ( ), 10 ( ), 18 ( ), 30
( ), 56 ( ), and 100 nM ATP
( ). The lines represent ﬁts
of a monoexponential func-
tion to the data (6–18 deter-
minations per data point).
(C) ATP concentration de-
pendence of steady-state de-
sensitization. Steady-state
desensitization levels repre-
sented by Iss values were
derived from the exponen-
tial ﬁts of (B). The curve rep-
resents a nonlinear ﬁt of the
Hill equation to the data (K1/2   3.2   0.1 nM, n   1.24   0.06; 6–13 determinations per data point). The value at 1 nM ATP was obtained
by preincubating the oocytes for 2 h at 1 nM ATP in a Petri dish before transferring them to the superfusion chamber, where the residual
current response was elicited by the 30  M ATP test pulse. (D) ATP concentration dependence of  od, the time-constant of onset of desen-
sitization.  od values are derived from the nonlinear ﬁts shown in (B).T
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steady-state level of desensitization attained in the con-
tinuous presence of ATP. This steady-state level of de-
sensitization is attained when the rate at which P2X1 re-
ceptors enter the desensitized state equals the rate at
which P2X1 receptors recover from the desensitized
state in the continuous presence of the respective ATP
concentration. With increasing ATP concentrations in
the superfusion bath, both the rate of onset of desensi-
tization and the steady-state level of desensitization in-
creased.
To determine the ATP dependence of this process,
steady-state desensitization levels represented by Iss val-
ues derived from exponential ﬁts (Fig. 2 B) were plot-
ted against the respective ATP concentration (Fig. 2 C).
Fitting the Hill equation to the data yielded an K1/2
value of 3.2   0.1 nM. The Hill coefﬁcient of 1.24  
0.06 suggests that more than one ATP molecule must
bind to desensitize the receptor. The use of the Hill
equation is based on the assumption that the kinetic
behavior of the P2X1 receptor can be described by a cy-
clic pseudo three-state model with C (closed or resting
state), O (open state), and D (desensitized state) (Reac-
tion diagram 1), 
Potentially existing additional conformational transi-
tions between states D and C are combined to the rate
constants k 3 and k 3. The residual current at the end
of the preincubation is proportional to the steady-state
occupancy of C, which can be written as
where Etot signiﬁes the totalized occupancies of C, O,
and D; K1/2 encompasses all six rate constants of the ki-
netic model:
(1)
It is apparent from Fig. 2 B that the onset time constant
of desensitization  od decreased with increasing ATP
concentrations. The relationship between  od and the
ATP concentrations is shown in Fig. 2 D.
Time Course of Recovery from Desensitization
In the previous paragraph we showed that nanomolar
ATP concentrations cause profound desensitization on
a slow time scale. The half-maximum steady-state de-
sensitization occurred at 3.2   0.13 nM ATP, at 3 nM
ATP steady-state desensitization developed with the
time constant     6.5 min. As a proof for the steady-
state criterion, it should be expected that recovery
from desensitization occurs at a time scale similar to
C ATP
kact
↔
k 1 –
OATP
kdes
↔
k 2 –
DATP
k 3
↔
k 3 –
...C ATP + +
CE tot 1 ATP [] K12 ⁄ ⁄ ()
n + {} , ⁄ =
K12 ⁄
k 1 – k 3 kdesk 3 k 1 – k 2 – ++
kact k 2 – kdes k 3 ++ () k 3 – k 1 – k 2 – kdes ++ () +
-------------------------------------------------------------------------------------------------------------. =
the development of desensitization at 3 nM ATP. To de-
termine the recovery time course we used a protocol
where 200 nM ATP was repetitively applied for a dura-
tion of 60 s in intervals ranging from 1 to 60 min. Be-
tween ATP applications oocytes were washed in ATP-
free Mg-ORI. One minute after each of these ATP ap-
plications generating the current responses of interest,
a control response to 200 nM ATP was elicited followed
by a second one again after 1 min in ATP-free Mg-ORI.
The ﬁrst control response was used to normalize the
preceding response of interest, the second one served
for the conﬁrmation of the ﬁrst control. Fig. 3 shows
the result of the recovery experiments. The data could
be ﬁtted by a monoexponential function indicating
that recovery from desensitization does not involve a se-
ries of conformational changes, or that only one con-
formational change between desensitized state D and
closed state C is rate determining. The time constant of
recovery amounted to      11.6    1.0 min which is
about twice the value of the time constant for develop-
ment of steady-state desensitization at 3 nM ATP. Since
Eq. 1 can be reduced to:
 
under certain assumptions (see discussion), the factor
2 between the two time-constants can be regarded as
being compatible with our simple kinetic model: At 3
nM ATP, close to the K1/2 value for steady-state desensi-
tization, the model predicts that k 3 and kact are about
equal. The rate constant derived from the recovery ex-
periments is identical to k 3, whereas the measured
K12 ⁄
kdesk 3
kactkdes
------------------
k 3
kact
-------- ==
Figure 3. Recovery from desensitization. Test responses were
elicited by 200 nM ATP applied for a duration of 60 s in intervals
ranging from 1 min to 60 min. Between ATP applications oocytes
were washed in ATP-free Mg-ORI. One minute after each test re-
sponse, a control response to 200 nM ATP was elicited which was
used to normalize the preceding response of interest. The solid
line represents the ﬁt of a monoexponential function to the data
yielding the time constant     11.6   1.0 min (N   4–7).T
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rate constant from the steady-state desensitization ex-
periments is the sum of k 3 and kact. This leads directly
to the factor 2 between the two experimentally deter-
mined rates for development of and recovery from de-
sensitization.
P2X1 Receptor–mediated Currents Elicited by Submicromolar 
ATP Concentrations
Half-maximum P2X1 receptor peak responses are typi-
cally observed at ATP concentrations around 1  M.
Since nanomolar ATP concentrations can effectively
desensitize the P2X1 receptor (compare Fig. 2), we ana-
lyzed the current responses at nanomolar ATP levels in
greater detail to examine whether desensitization at
low ATP involves channel opening or not. Fig. 4 A
shows the dose-response curve for ATP concentrations
ranging from 1 nM to 30  M. Two different protocols
were used to determine the ATP dependence of peak
currents at ATP concentrations lower and higher than
100 nM, respectively. Between 100 nM and 10  M ATP
each current measurement at an ATP concentration re-
quired to establish the dose-response curve was pre-
ceded and followed by a measurement of the maxi-
mum current response to 30  M ATP as an internal
control. To this end, 5-s ATP pulses were repetitively ap-
plied in intervals of exactly 60 s. To overcome the prob-
lem that a short pulse with a low ATP concentration
causes only a fraction of the total P2X1 receptor pool to
desensitize, a 5 s lasting pulse of 30  M ATP was always
applied immediately before the 60-s recovery period to
induce all P2X1 receptors to enter the desensitized
state. Accordingly, no other P2X1 receptors than those
that recovered from the desensitized state during the
60-s recovery period were available for activation by the
next test pulse of ATP. In this way, current measure-
ments used for the dose-response curve could be nor-
malized to the respective ﬂanking control current re-
sponses to 30  M ATP, thus minimizing the inﬂuence
of current run-down and related phenomena on the re-
sults. At ATP concentrations between 1 and 30 nM cur-
rents are too small to be dependably resolved. There-
fore, we used responses elicited directly after impaling
the oocytes for determination of peak currents at these
low ATP concentrations. These responses were normal-
ized to the mean of control responses elicited by 30  M
ATP also directly after impalement. To this end, every
oocyte was used only once and discarded thereafter.
Despite the two different protocols used both datasets
Figure 4. Analysis of P2X1
receptor activation at submi-
cromolar ATP concentra-
tions. (A) ATP dose-response
curve for 1 nM to 30  M ATP
(EC50   0.7   0.06  M, n  
1.13   0.08; mean of 11–
55 determinations per data
point). (B) Scaled current
traces elicited by 10–300 nM
ATP. ATP was applied until
the desensitization process
was completed (10 min at 10
nM ATP; 10 s at 300 nM). The
gray curves underlying the
original current traces (in
black) represent ﬁts of the
Bateman equation to the
data. (C) ATP concentration
dependence of activation ( )
and desensitization ( ) time-
constants (21–70 determina-
tions per data point). The
solid line represents a ﬁt of
equation         0[ATP] n to
the data points (n   1.75  
0.02). In addition, time con-
stants of onset of desensitiza-
tion ( ) taken from Fig. 2 D
were replotted to demon-
strate that they follow a virtu-
ally identical ATP depen-
dence. (D) Areas under current traces elicited by 18–300 nM ATP (11–51 determinations per column). The areas were calculated using
the parameters obtained by ﬁtting the Bateman function to the current traces in (A). Numerical integration of the receptor currents
yielded virtually identical results (not depicted).T
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could be combined in one plot and ﬁtted by a single
Hill equation yielding an EC50 value of 0.7  M and a
Hill coefﬁcient of 1.13. For the kinetic description of
the current transients, which are proportional to the
occupancy of the open state, we considered the model:
This model is deduced from Reaction diagram 1 by
omitting recovery from desensitization (D → C) and
backward reactions (D → O and O → C). Quantita-
tively, this reaction diagram can be handled by the
Bateman equation, which has ﬁrst been used to de-
scribe the radioactive decay of a parent element into a
daughter nucleus, which itself is radioactive (Bateman,
1910).
(2)
kact and kdes are the rate constants of receptor activation
and desensitization, respectively, and I0 is the receptor
current that would be observed without receptor de-
sensitization (kdes   0). Fig. 4 B shows individual P2X1
receptor current traces activated by application of 10–
300 nM ATP. The original current traces were scaled to
approximately the same size to visualize their excellent
agreement with the underlying gray lines, representing
the nonlinear least-squares ﬁts of Eq. 2 to the current
traces. The rate of current decay increased strongly
with the ATP concentration. Plotting the time con-
stants   (    1/k) derived from the ﬁt of the Bateman
equation to the current traces versus the ATP concen-
tration showed that the time constants of the decaying
phase of the current traces are strongly ATP depen-
dent, whereas the time constants of current onset seem
to be virtually ATP independent (Fig. 4 C). The ATP
dependence of the decay time constants can be ade-
quately described by the equation      0[ATP] n, with
n   1.75;  0 signiﬁes the time constant at 1 nM ATP
(Fig. 4 C). Fig. 4 C also shows the time constants of on-
set of desensitization derived from the steady-state mea-
surements. The very similar ATP dependence of both
datasets is consistent with the view that time constants
of onset of desensitization and of decay of the current
response both have identical kinetic origin.
It seems plausible to assign kact and kdes of the Bate-
man equation to the rate constants of the rise and de-
cay components of the current traces, respectively.
However, the Bateman equation possesses the charac-
teristic feature that the decay phase does not a priori
reﬂect kdes, but rather the process, which exhibits the
lowest rate constant, i.e., kact or kdes. In other words,
identically shaped current traces can be expected inde-
pendent of whether receptor activation or deactivation
represents the ATP concentration–dependent reaction
C
kact
→ O
kdes
→ D.
It ()
I0 kact ⋅
kdes kact –
------------------------ kact – t () exp kdes – t () exp – [] . =
as long as the ATP concentration–dependent step is
slow compared with the other one. A discrimination be-
tween the two possibilities—ATP dependence of either
kact or kdes—can be made on basis of the consideration
that an ATP concentration–dependent acceleration of
the desensitization reaction would result in current
peaks that decrease at increasing ATP concentrations.
Since this is obviously not the case, we conclude that
the decay phase reﬂects the rate of receptor activation
rather than receptor desensitization and consequently
that the desensitization reaction at low ATP occurs
much faster than the activation reaction (kdes    kact).
At ATP concentrations  100 nM the rate of current on-
set becomes faster than the desensitization rate con-
stant kdes and the decay of the current is then deﬁned
by the desensitization rate constant.
Since the area under a current trace, AUC, is repre-
sented by the integral of the Bateman equation, 
the linear three-state-model predicts further that the
AUC values are independent of the ATP concentration
provided that the rate constant of desensitization, kdes,
is ATP independent as concluded above. To test this
prediction, the AUC values were calculated for ATP
concentrations between 18 and 300 nM. Fig. 4 D shows
the calculated areas normalized to the area at 30 nM
ATP and demonstrates that there is indeed no obvious
ATP dependence of the AUC at concentrations be-
tween 18 and 300 nM ATP. The ATP independence of
the AUC values corroborates our view that the ATP de-
pendence of the decay phases reﬂects the ATP depen-
dent activation rate constant kact at   100 nM ATP.
DISCUSSION
The present study shows that the rat P2X1 receptor,
which requires 0.7  M ATP for half-maximum activa-
tion, becomes profoundly desensitized in the continu-
ous presence of  200-fold lower ATP concentrations.
Inactivation by low concentrations of a continuously
present agonist has previously been observed to occur
with various neurotransmitters and drugs, including se-
rotonin (Neijt et al., 1989; Bartrup and Newberry,
1996), acetylcholine (Boyd and Cohen, 1980), and nic-
otine (Dani and Heinemann, 1996). For the nicotinic
receptors it has been shown that this type of desensiti-
zation, which occurs without receptor activation, results
from the direct binding of an agonist to a desensitized
receptor state D*, which has a several hundredfold
higher agonist afﬁnity than the resting receptor state R.
The high afﬁnity, desensitized receptor pool is in equi-
librium with the unliganded resting receptors, and ac-
counts for  20% of the nicotinic receptors in the ab-
sence of agonist (Heidmann and Changeux, 1979). Oc-
AUC I t ()
I0
kdes
-------- , =
0
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cupation of these high afﬁnity sites at low agonist
concentrations drives R through D* toward D*·agonist,
leading to receptor desensitization without concomi-
tant channel opening.
Steady-state Desensitization by ATP Cannot be Attributed to a 
High Afﬁnity Predesensitized P2X1 Receptor Pool
In obvious contrast to these results, we observe signiﬁ-
cant P2X1 receptor–mediated currents at the same na-
nomolar concentrations of ATP, which eventually drive
large fractions of the total P2X1 receptor pool into a de-
sensitized conﬁguration, from which they recover very
slowly. From the identical total areas under the current
transients, we infer that the same number of receptors
are activated irrespective of whether the activation oc-
curs slowly or rapidly at low or high ATP concentra-
tions, respectively. Current traces elicited by ATP con-
centrations   18 nM, which are too low to produce
near-to-complete desensitization, were not included in
the area evaluation to exclude a signiﬁcant current
contribution by P2X1 receptors that recover from the
desensitized state during the observation period. The
important conclusion from these observations is that
low ATP concentrations desensitize the P2X1 receptor
by binding to the resting receptor state R rather than
by binding to a desensitized high afﬁnity state D*. This
conclusion is also corroborated by the ﬁnding that de-
cay of receptor current and onset of desensitization fol-
low the same time course. Accordingly, desensitization
by nanomolar concentrations of ATP cannot be attrib-
uted to the existence of a population of high afﬁnity
predesensitized P2X1 receptors, but must be inherent
to other steps of the reaction pathway.
Fast Desensitization as a Determinant of Micromolar ATP 
Potency for Receptor Activation
But how then explain the large difference between the
EC50 value for receptor activation and the K1/2 value for
steady-state desensitization of 0.7  M  vs. 3.2 nM, re-
spectively? The EC50 value for P2X1 receptor activation
is derived from peak current measurements, which re-
ﬂect ATP binding to the receptor followed by channel
opening and rapid desensitization. The use of the Hill-
equation to describe steady-state desensitization was
based on reaction diagram 1 (see results). This
scheme can be further simpliﬁed by assuming that k 1
and k 2 are negligibly small (both rate constants can be
set to zero for appropriate description of receptor cur-
rents, see results). Assuming further that kdes    k 3,
i.e., that desensitization occurs much faster than recov-
ery from desensitization, and kact    k 3, i.e., that ATP
binding leads predominantly to channel opening and
not directly to desensitization, the above equation re-
duces to
K12 ⁄
kdesk 3
kactkdes
------------------
k 3
kact
-------- . ==
Figure 5. Analysis of simu-
lated receptor currents. Re-
ceptor currents were simu-
lated for the cyclic three-state
model by using the Gepasi
Software and analyzed in the
same manner as the experi-
mental data. (A) ATP depen-
dence of simulated peak cur-
rents in dependence of as-
sumed genuine KD values for
receptor activation of 0.03
( ), 3 ( ), 30 ( ), 100 ( ),
300 ( ) and 1.000 nM ( ). A
ﬁt of the Hill equation to the
simulated data yielded EC50
values of 0.72–1.3  M for KD
values ranging from 0.03 to
1,000 nM, respectively. (B)
Relative deviations of the cal-
culated EC50 taken from A
from the experimentally de-
termined EC50 value in de-
pendence of the assumed
genuine KD values. (C)
Steady-state desensitization
was calculated using the same
set of simulated currents as in
(A). A ﬁt of the Hill equation resulted in apparent K1/2 values of 3.4–8.3 nM for KD values of 0.03–1,000 nM, respectively. (D) Relative devi-
ations from the calculated K1/2 values from the experimentally determined K1/2 value in dependence of genuine assumed KD values.T
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This simpliﬁed equation can be assigned to a two-state
model, 
where kact is now the apparent desensitization rate con-
stant; k 3 remains the rate constant of recovery from
desensitization. This signiﬁes that steady-state desensiti-
zation is approximately determined by the activation
rate constant kact and the recovery rate constant k 3.
The validity of this simpliﬁcation is strengthened by the
ﬁnding, predicted by the model, that development of
steady-state desensitization at 3 nM ATP occurs at a rate
twice as fast as the rate of recovery from desensitization.
In the cyclic three-state reaction scheme, closure of re-
ceptor state O occurs by both backward reaction to the
closed state C and forward reaction to the desensitized
state D with the dissociation rate constant for agonist
unbinding k 1 and the desensitization rate constant
kdes, respectively. If k 1 is slow compared with kdes, the
apparent afﬁnity of the receptor deduced from the
ATP concentration–dependent magnitude of peak cur-
rents is determined by the quotient of kact and kdes,
rather than by the genuine ATP binding afﬁnity of the
receptor, which is given by k 1/kact. In other words, ap-
parently as a result of the rapid rate of receptor desen-
sitization and the comparably slow rate of ATP unbind-
ing, peak current measurements provide a determina-
tion of the EC50 value under nonsteady-state conditions
(Leff, 1986). Hence, the EC50 value of 0.7  M does not
reﬂect ATP binding equilibrium, since virtually all acti-
vated P2X1 receptors close by a O → D transition rather
than by a O → C transition.
The view that kdes    k 1 is supported by model cal-
culations showing that the characteristics of steady-state
desensitization as well as receptor currents can be ade-
quately described by a reaction model, in which the dis-
sociation rate constant k 1 is set to zero. Using the ex-
perimentally determined values for kact and k 3, with
k 1, k 2, and k 3 set to zero, simulated receptor cur-
rents were generated with the Gepasi software for the
cyclic three-state reaction model. By analyzing these
data in the same way as the experimental data, K1/2 val-
ues were obtained that amounted to 0.7  M and 3.2 nM
for ATP-dependent current activation and steady-state
desensitization, respectively, which are identical to the
experimentally determined values (Fig. 5, A and C).
The High ATP Afﬁnity for Steady-state P2X1 Receptor 
Desensitization Is Predominantly Determined by Fast 
Desensitization Combined with Extremely Slow Recovery
While these considerations illuminate the low ATP po-
tency for P2X1 receptor activation and corroborate that
our models can predict the distinct K1/2 values, it re-
mains unclear which reaction step is responsible for
C ATP
kact
↔
k 3
DATP, +
the 3.2 nM afﬁnity of steady-state desensitization. A pos-
sible candidate for a high ATP afﬁnity is the resting
state C itself. However, the genuine ATP afﬁnity of state
C cannot be directly deduced from our models, since
the Bateman equation solely provides an estimate of
the on rate constant kact, whereas the off rate constant
k 1 is considered to be negligibly low in our reaction
models on the basis of k 1    kdes. To provide a rough
estimate of the upper limit of the dissociation rate con-
stant k 1, we generated numerically simulated receptor
currents using again the experimentally determined
rate constants, with the sole exception that k 1 was not
set to zero, but varied to produce genuine KD values
(equal to k 1/kact) of 10 2 to 103 nM. The resulting
ATP-dependent currents were analyzed in the same way
as the experimental data. Fig. 5, A and C, shows the
dose-response curves for simulated receptor activation
and steady-state desensitization in dependence of the
chosen genuine KD values for ATP. Fig. 5, B and D, de-
picts the relative deviations of the simulated EC50 values
for activation and the K1/2 value for steady-state desensi-
tization from the experimentally determined values
(0.7  M and 3.2 nM, respectively). In both cases signiﬁ-
cant deviation from the experimental data occurs at KD
 100 nM. Below 100 nM ATP, the values for both acti-
vation and steady-state desensitization were found to be
virtually independent of the intrinsic ATP binding af-
ﬁnity of the P2X1 receptor. From these model calcula-
tions, we conclude that the intrinsic ATP afﬁnity of the
P2X1 receptor must be  100 nM; therefore, an intrin-
sic ATP afﬁnity in the low nanomolar range is neither
excluded nor supported by our data. In any case, the
low K1/2 value of 3.2 nM for steady-state P2X1 receptor
desensitization is related to the extremely slow recovery
of the P2X1 receptor from the desensitized state such
that the apparent afﬁnity approximates k 3/kact. It is in-
teresting to note that a binding afﬁnity in the nanomo-
lar range has been observed in tissues expressing native
P2X receptors in early radiotracer binding experiments
using the agonists [35S]ATP and [3H]  -methylene
ATP as ligands (Bo and Burnstock, 1990; Michel and
Humphrey, 1993). If recovery from desensitization is
rate limited by agonist dissociation rather than an
agonist-independent conformational change, the K1/2
value for steady-state desensitization of our study and
the binding afﬁnity found in the radiotracer experi-
ments could have the same physical origin.
It has been shown that P2X1 receptor channels have
a single-channel conductance of  19 pS and that open-
ings occur in brief ﬂickery bursts (Evans, 1996). This
ﬂickery behavior is not considered by our simple ki-
netic model, but can easily be introduced by the addi-
tion of an explicit opening reaction by inserting a
closed ATP-liganded state between C and O. Another
feature at the single-channel level is that P2X receptorsT
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continuously exposed to ATP reopen after longer peri-
ods of closure. This reopening is already supported by
our model in the present form, in which recovery from
desensitization occurs on a slow time-scale without
channel opening.
Altogether, our data indicate that the kinetic behav-
ior of the P2X1 receptor resembles in several aspects
that of LGIC of the nicotinic superfamily, including its
high sensitivity to low concentrations of continuously
present agonist, which drive large fractions of the re-
ceptor into a desensitized state. However, the underly-
ing mechanism that accounts for desensitization at low
agonist concentrations seems to be fundamentally dif-
ferent. The high sensitivity of nicotinic receptors to de-
sensitization by a continuously present agonist results
from the existence of a signiﬁcant fraction of the recep-
tor in a high afﬁnity desensitized state, which is in equi-
librium with the resting state, and to which the agonist
binds without opening the channel. In contrast, the
P2X1 receptor must ﬁrst open to desensitize even at low
ATP concentrations, indicating that an unliganded
high-afﬁnity desensitized P2X1 receptor state D* does
not contribute signiﬁcantly to the desensitization pro-
cess at the examined ATP concentrations. The appar-
ent ATP afﬁnities for channel activation and steady-
state desensitization are predominantly determined by
receptor desensitization and recovery from desensitiza-
tion, respectively, in both cases in combination with re-
ceptor activation. The rapid rate of receptor desensiti-
zation results in an apparent ATP afﬁnity in the 0.7  M
range, whereas the extremely slow recovery from the
desensitized state leads to a 200-fold higher apparent
afﬁnity for continuously present ATP causing steady-
state desensitization. Our model calculations indicate
that the resting P2X1 receptor possesses an intrinsic
ATP afﬁnity of  100 nM. Up to this concentration, the
intrinsic ATP afﬁnity seems to have no inﬂuence on the
K1/2 values for receptor activation and desensitization.
Since these different effects of ATP on the P2X1 re-
ceptor are separated by more than two orders of magni-
tude, desensitization can be fully developed before cur-
rent activation becomes signiﬁcant. The extent to
which synaptic transmission is physiologically limited
by P2X receptor desensitization is not clear. However,
since signiﬁcant extracellular ATP concentrations are
attained under a variety of physiological and patho-
physiological conditions such as ischemic tissue dam-
age (Rathbone et al., 1999), the long-lasting refractory
closed state suggests that P2X1 receptor responses can
be obscured in vivo by unexpectedly low concentra-
tions of ATP.
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